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Summary
Background: Ionotropic glutamate receptors (iGluRs) are
glutamate-gated ion channels that mediate excitatory neuro-
transmission in the central nervous system. Based on both
molecular and pharmacological criteria, iGluRs have been
divided into two major classes, the non-NMDA class, which
includes both AMPA and kainate subtypes of receptors, and
the NMDA class. One evolutionarily conserved feature of
iGluRs is their desensitization in the continued presence of
glutamate. Thus, when in a desensitized state, iGluRs can be
bound to glutamate, yet the channel remains closed. However,
the relevance of desensitization to nervous system function
has remained enigmatic.
Results: Here, we report the identification and characteriza-
tion of a novel polypeptide (con-ikot-ikot) from the venom of
a predatory marine snail Conus striatus that specifically
disrupts the desensitization of AMPA receptors (AMPARs).
The stoichiometry of con-ikot-ikot appears reminiscent of
the proposed subunit organization of AMPARs, i.e., a dimer
of dimers, suggesting that it acts as a molecular four-legged
clamp that holds the AMPAR channel open. Application of
con-ikot-ikot to hippocampal slices caused a large and rapid
increase in resting AMPAR-mediated current leading to
neuronal death.
Conclusions: Our findings provide insight into the mecha-
nisms that regulate receptor desensitization and demonstrate
that in the arms race between prey and predators, evolution
has selected for a toxin that blocks AMPAR desensitization,
thus revealing the fundamental importance of desensitization
for regulating neural function.
Introduction
Fast, excitatory neurotransmission in the vertebrate nervous
system is primarily mediated by the neurotransmitter gluta-
mate, which activates two major classes of pore-forming ion-
otropic glutamate receptors (iGluRs) that are distinguished
on the basis of molecular and pharmacological criteria. Of
these, the receptors activated by a-amino-3-hydroxyl-5-
*Correspondence: maricq@biology.utah.edumethyl-4-isoxazole-propionate (AMPARs) have a primary
role in the transient depolarization of the postsynaptic
membrane caused by synaptic release of glutamate [1]. The
time course of AMPAR-mediated changes of the synaptic
potential is rapid, on the order of milliseconds, and is influ-
enced both by the rate at which glutamate is removed from
the synaptic cleft and by the processes of receptor deactiva-
tion and desensitization. AMPARs are tetrameric arrange-
ments of four subunits assembled as a dimer of dimers [2].
Binding of glutamate to the S1-S2 extracellular regions of an
individual subunit causes a conformational change of the
receptor leading to pore opening [3, 4]. In the continued
presence of glutamate, an additional conformational change
closes the pore—this process is called desensitization [5].
Recent studies indicate that at least three classes of auxiliary
proteins modulate the kinetics of AMPAR desensitization [6–9].
Members of the transmembrane AMPAR regulatory protein
(TARP) family have been identified in both vertebrates [10]
and invertebrates [8]. Vertebrate TARPs act as obligate chaper-
ones for AMPAR export from the endoplasmic reticulum,
localize AMPARs to synapses, and contribute to AMPAR
desensitization and deactivation kinetics [6]. More recently, in
invertebrates a second class of AMPAR auxiliary proteins
has been described [7, 9, 11]. The founding member of these
CUB-domain-containing proteins, SOL-1, was identified in
C. elegans and shown to slow the rate of AMPAR desensitiza-
tion. sol-1 mutants have disrupted glutamatergic neurotrans-
missionandAMPAR-dependent behaviors, thusdemonstrating
the biological importance of regulating iGluR desensitization.
Related CUB-domain proteins have now been identified in
vertebrates and modify the kinetics of NMDA and kainate
receptors [12, 13]. Finally, a recent study showed that corni-
chon, a three-pass transmembrane protein, associates with
AMPARs and modulates the kinetics of deactivation and desen-
sitization [14].
The cell body and dendrites of mammalian hippocampal CA1
neurons express extrasynaptic and synaptic AMPARs that can
exchange locations [15–18] and that associate with auxiliary
proteins that are known to strongly affect the biophysical pro-
perties of the receptors [6, 11, 19–21]. Studying how desensiti-
zation contributes to the function of these classes of AMPARs
has been difficult because existing modulators of AMPAR
desensitization are nonspecific. For example, the widely used
drug cyclothiazide (CTZ), which blocks AMPAR desensitiza-
tion, also blocks ionotropic GABA receptors [22], facilitates
presynaptic release by suppressing potassium currents [23],
and also increases the AMPAR affinity for glutamate [24].
Therefore, new pharmacological agents are required for
a rigorous test of the contribution of desensitization to neuronal
AMPARs. We hypothesized that toxins elaborated by preda-
tors may have evolved to target receptor desensitization.
Therefore, we screened venoms from various species ofConus
snails [25] for toxins that specifically disrupted the desensitiza-
tion of AMPAR-mediated glutamate-gated currents.
Here, we report the discovery and characterization of a toxin
(con-ikot-ikot) from the fish-hunting snail Conus striatus [26].
We show that con-ikot-ikot has a profound effect on AMPAR-
mediated currents by inhibiting channel desensitization. The
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901Figure 1. Isolation and Identification of Con-ikot-ikot
(A) Glutamate-gated currents recorded fromXenopusoocytes that expressed GluA1(flop) before (2venom), and 1 min after (+venom) or 40 min after (+ 40 min)
the application of 0.18 mg venom from Conus striatus. Gray record is a scaled version of –venom trace. Application of 1 mM glutamate indicated by bar.
(B) Final reverse-phase HPLC separation of the active component (arrow).
(C) MALDI spectra of the active component. Peaks 1 and 2 correspond to the predicted molecular weights of the monomeric and dimeric peptides.
(D) Con-ikot-ikot amino acid sequence. Black box, predicted signal sequence; underline, propeptide; and gray box, sequence determined by Edman
degradation.effect was specific for AMPARs and con-ikot-ikot binds to a site
distinct to that of CTZ. Con-ikot-ikot is a much larger peptide
than previous toxins isolated from cone snails, and the active
protein appears to be formed from a dimer of dimers thus
mimicking the proposed stoichiometry of iGluRs. The unprece-
dented biochemical properties of this toxin suggest that it might
act as a molecular four-legged clamp which, when bound to the
iGluR channel, locks it in an open conformation. In addition to
providing a mechanistic insight into receptor desensitization,
the discovery of this novel Conus snail toxin may present an
opportunity for the development of therapeutic drugs that
modulate this important aspect of nervous system function.
Results
Conus striatus Venom Contains a Peptide that Blocks
AMPAR Desensitization
To identify molecules that modulate iGluR desensitization,
we screened a number of Conus venoms for activities thatmodified glutamate-gated currents in Xenopus oocytes that
expressed the GluA1 (GluR1) AMPAR subunit [27]. In the
absence of venom, we recorded small, rapidly desensitizing
currents in response to bath application of 1 mM glutamate
(Figure 1A). In contrast, preincubation with venom from Conus
striatus increased the size of the peak current by over an
order of magnitude; however, the before and after currents
do not scale, presumably a consequence of a toxin-mediated
decrease in the rate of receptor desensitization (Figure 1A).
The effect was still evident after a 40 min wash (Figure 1A).
After serial HPLC fractionation of the venom, we identified
a single peak (Figure 1B) with biological activity identical to
that of the original fraction (data not shown). MALDI mass
spectrometry showed two major peaks with average mole-
cular weights of 9,443 and 18,868 kD (Figure 1C). These results
were confirmed by electrospray mass spectrometry analysis,
which also revealed two peaks centered at 18,864 kD (primary)
and 9,433 (secondary) (data not shown). Peptide sequencing
produced a 27 amino acid (aa) N-terminal sequence on which
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cDNA from Conus striatus. The cDNA encodes a predicted 123
aa peptide with an 18 aa signal sequence, a 19 aa propeptide
region, and an 86 aa mature peptide with 13 cysteines and
a calculated molecular weight of 9,432 kD (Figure 1D). This
weight is in close agreement with the mass spectrometry esti-
mates. We named this toxin con-ikot-ikot (ikot-ikot is a Filipino
word that translates to ‘‘spinning around’’ or ‘‘turning around,’’
a reference to the swimming phenotype observed in fish
injected with the toxin [see below]).
Active Con-ikot-ikot Is Formed from a Dimer of Dimers
To establish that con-ikot-ikot was the active component of the
venom, we expressed a 6xHis-tagged thioredoxin-toxin fusion
protein in bacteria. The recombinant protein was concentrated
by Ni2+ column chromatography, treated with protease to
release the toxin, and further fractionated by HPLC, which
revealed a chromatogram consisting of three major peaks.
Peak 1 was the major component and first to elute, followed
by minor peaks 2 and 3 (Figure 2A). When tested for the ability
to block AMPAR desensitization in oocytes, peaks 1 and 3
had little activity, whereas peak 2 slowed the kinetics of desen-
sitization, thus greatly increasing the current magnitude
(Figure 2B). Analysis of the peaks and native toxin by gel elec-
trophoresis revealed three major bands (Figure 2C). In the
Figure 2. Active Con-ikot-ikot Toxin Is a Dimer of
Dimers
(A) Reverse-phase HPLC chromatogram of re-
combinant, column-purified con-ikot-ikot (see
Experimental Procedures). Three major fractions
were isolated.
(B) Glutamate-gated currents recorded from
Xenopus oocytes expressing GluA1(flop) and
treated with fractions 1, 2, or 3 (6 mM).
(C) SDS-PAGE of native and recombinant toxin.
Indicated are the fractions described above, the
refolded fraction 1 (1R), and the native toxin (N).
Reducing conditions included 1 mM DTT.
(D) HPLC chromatograms showing fraction 1 and
refolded fraction 1 (1R) of the recombinant toxin.
Time of incubation (hr) of fraction 1 in mixture of
oxidized and reduced glutathione indicated
next to trace.
(E) SDS-PAGE after RIPA buffer incubation of
native and recombinant toxin. Reducing condi-
tions included 1 mM DTT.
inactive peak 1 fraction, we observed a
dominant band at approximately 9.5 kD
(monomer), a minor band at roughly
twice this size (19 kD), and no band at
a position corresponding to four times
the size (38 kD). In the inactive peak 3
fraction, we observed only a 19 kD
band (dimer). In contrast, in the active
peak 2 fraction, we observed a predomi-
nant 38 kD band (tetramer) as well as the
minor 19 kD band. The bands observed
in peak 2 were identical to that of native
toxin. Protein refolding experiments
showed that the inactive monomeric
species could be converted to an active
tetramer under conditions that promoted
oxidation/reduction (1R) (Figures 2C and
2D). All bands collapsed to the monomeric form under reducing
conditions (Figure 2C). Prolonged incubation of native toxin in
RIPA buffer changed the ratio of bands from predominantly
tetrameric to dimeric (Figure 2E). These data, together with
the mass spectrometry results (Figure 1C), suggest that con-
ikot-ikot forms a covalently linked dimer, presumably through
an unpaired cysteine in the monomer, and that the mature toxin
is a noncovalently linked dimer of dimers (Figures 2C and 2E).
Many Conus toxins are covalently modified posttranslation-
ally [28]. To verify that recombinant con-ikot-ikot from the peak
2 fraction was equivalent to the native toxin, we showed that
these peptides had identical coelution profiles (Figure 3A),
molecular weight by MALDI (9,433 and 18,865; data not
shown), and biological activity (Figure 3B).
Con-ikot-ikot Activity Is Specific for a Subset of iGluRs
To assess the pharmacological specificity of con-ikot-ikot, we
tested its ability to modify the desensitization of different
classes of ligand-gated ion channels [1], including the iGluRs
preferentially activated by either kainate or N-methyl-D-
aspartic acid (NMDA) and GABA receptors. We found that
whereas con-ikot-ikot enhanced either the flip or flop variants
of the GluA1 AMPAR, it had no detectible activity on GluK2
(GluR6) kainate receptors (Figures 4A and 4B), GluN1/GluN2A
(NR1/NR2A) NMDA receptors (data not shown), or GABA-A
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903receptors (data not shown). The greater enhancement for
GluA1 flop versus flip is the opposite of that observed for
CTZ [29]. We also observed enhancement of GluA2 (GluR2),
GluA3 (GluR3), and GluA4 (GluR4) AMPAR-mediated currents
(data not shown).
Modulation by Con-ikot-ikot Does Not Require
the N-Terminal Domain of GluA1
We characterized the potency of con-ikot-ikot by evaluating its
dose-response relation. Con-ikot-ikot had an apparent EC50 of
67 nM (Figure 5A); however, this value is almost certainly an
underestimate because of the relatively slow rate of perfusion
in our oocyte recording chamber, which limits the detection of
fast currents. In contrast to the marked effects on receptor
desensitization, the toxin did not modify the current-voltage
relation, indicating that ion permeation was not altered by
toxin (Figure 5B). In addition, the estimated EC50 from the
dose-response relation in the presence of toxin is 419 mM,
which is consistent with published results [1] and suggests
that the toxin did not increase the affinity for glutamate
(Figure S1 available online). The extracellular portion of iGluRs
consists of a large N-terminal domain and two smaller regions
Figure 3. Recombinant Con-ikot-ikot Is Equiva-
lent to the Native Toxin
(A) HPLC coelution of native and recombinant
con-ikot-ikot.
(B) Glutamate-gated current traces from Xeno-
pus oocytes that expressed GluA1(flop) before
and after application of 6 mM recombinant con-
ikot-ikot.
Figure 4. Con-ikot-ikot Specifically Targets a Subset of iGluRs
(A) Current traces from Xenopus oocytes that express GluA1(flip), GluA1(flop), and GluK2 before (control) and after toxin application.
(B) Average relative increase of peak current in response to con-ikot-ikot application. *p < 0.02 (Mann-Whitney; n = 8, GluA1-flip; n = 5, GluA1-flop; n = 5,
GluK2).
defined as S1 and S2, the sites of gluta-
mate binding [2]. Previous work has
shown that recombinant receptors lack-
ing the N-terminal domain (DNT) were
functional and could be gated open by
glutamate [30]. To assess the necessity
of the GluA1 N-terminal domain for
toxin-mediated modulation, we tested
con-ikot-ikot on oocytes that expressed recombinant DNT-
GluA1(flip). We found that the toxin enhanced glutamate-gated
currents, indicating that the N-terminal domain was not critical
for con-ikot-ikot binding (Figure 5C).
Con-ikot-ikot and Cyclothiazide Bind to Distinct Sites
on GluA1
The nonspecific drug cyclothiazide (CTZ) is a well known
modulator of desensitization of AMPARs [31], causing block
of desensitization of GluA1(flip) receptors [29] and slowly
potentiating AMPAR-mediated currents [24]. To address
whether con-ikot-ikot and CTZ bound to a common site, we
examined the effects of CTZ preincubation on con-ikot-ikot
enhancement of GluA1(flip)-mediated current in Xenopus
oocytes. We found that the effects of 6 mM con-ikot-ikot were
long lasting and that preincubation of toxin-treated oocytes
with 100 mM CTZ did not block the effects of con-ikot-ikot,
although we did note an apparent decrease in the rate of deac-
tivation when both drugs were applied (Figure 6A). These
results indicate that the two drugs bind to different sites on
the receptor. To determine whether con-ikot-ikot can open
already desensitized GluA1 receptors, we first incubated
Figure 5. Con-ikot-ikot Potently Enhances AMPAR-Mediated Current
(A) Dose-response curve of glutamate-gated currents recorded from Xenopus oocytes that expressed GluA1(flip).
(B) Current-voltage curves before (control) and after con-ikot-ikot application.
(C) Glutamate-gated current in Xenopus oocytes that expressed an N-terminal deletion variant of GluA1(flip) (D60-471) both before (control) and after toxin
application.
Current Biology Vol 19 No 11
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then added toxin in the continued presence of glutamate
(Figure 6B). Toxin application was followed by a dramatic
increase in current that reached maximal amplitude in approx-
imately 3 min.
Con-ikot-ikot Is Active on Native Mammalian AMPARs
To examine whether the toxin had similar effects on native
AMPARs in mammalian neurons, we used whole-cell patch
clamp recordings to study CA1 pyramidal neurons in rat hippo-
campal slices. Bath application of 1 mM toxin resulted in
a dramatic increase in direct current (DC) during voltage-clamp
recordings that caused the loss of recordings within 5 min
(Figure 7A). The time course of this increase was similar to
that observed in ooctyes (Figure 6B). A less rapid increase in
DC occurred with 0.1 mM toxin, but stable recordings were still
lost after 10–12 min. Lower toxin concentrations (0.03 mM)
caused a smaller increase in DC that cells could tolerate. The
Figure 6. Con-ikot-ikot Blocks Desensitization of GluA1 and Increases Current
(A) Glutamate-gated currents inXenopusoocytes that expressed GluA1(flip) both before and after application of either toxin alone or toxin and 100 mM cyclo-
thiazide (CTZ).
(B) Con-ikot-ikot-induced current in Xenopus oocytes that expressed chronically desensitized GluA1(flip).
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905Figure 7. Con-ikot-ikot produces a standing AMPAR-mediated current in CA1 pyramidal neurons
(A) Direct current (DC) in whole-cell voltage-clamp recordings from CA1 pyramidal neurons in hippocampal slices during bath application of toxin (starting at
0 min) at concentrations indicated (n = 4 for 1 mM; n = 4 for 0.1 mM; n = 4 for 0.03 mM) and with the coapplication of 1 mM toxin and 10 mM NBQX (n = 3).
(B) EPSCs (scaled, averages of 12 traces) from an example experiment before and during toxin application.
(C) AMPAR-mediated EPSC amplitude during application of 0.1 mM toxin (n = 4).effects of 1 mM toxin on DC were completely blocked by coap-
plication of 10mM NBQX, demonstrating that the increase in DC
caused by the toxin was mediated by AMPARs (Figure 7A).
These findings demonstrate that the toxin caused massive
AMPAR activation in CA1 pyramidal neurons. To address
whether an increase in action potential frequency contributed
to the change in DC, we repeated the experiment in the pre-
sence of tetrodotoxin (TTX), a blocker of Na+-dependent action
potentials. We found that TTX did not block the toxin-induced
change in DC (Figure S2). We also monitored AMPAR-medi-
ated excitatory postsynaptic currents (EPSCs) during toxin
application to slices. We found that 0.1 mM toxin caused
a depression of EPSC amplitude and a small prolongation of
EPSC time course (weighted time constant from double expo-
nential fits in the absence and presence of 0.1 mM toxin were
18.0 6 0.9 ms and 24.5 6 1.6 ms, respectively, p < 0.05, n = 4)
(Figures 7B and 7C). The effect of toxin on EPSC time course
could be due to the toxin blocking a component of AMPAR
desensitization during EPSC decay and/or to a loss of voltage-
clamp efficiency caused by the increase in DC.
Con-ikot-ikot Blocks Desensitization of Extrasynaptic
AMPARs
To directly examine the effect of con-ikot-ikot on AMPARs, we
pulled outside-out patches from the soma of CA1 pyramidal
cells and used rapid perfusion techniques to examine gluta-
mate-gated currents. In the absence of con-ikot-ikot, the
current desensitized within milliseconds; however, after incu-
bation with toxin, desensitization was blocked (Figure 8A). By
using similar techniques, we also studied GluA1 receptors
expressed in HEK293 cells. Again, we found that incubation
with toxin blocked desensitization (Figure 8B), even during
prolonged applications of glutamate (Figure 8C). The toxin
also appeared to have a mild effect on the rate of receptor
deactivation (Figure S3).
Discussion
Con-ikot-ikot is likely to play an important role in the prey
capture strategy of Conus striatus given that it is a prominent
component of the venom from this fish-hunting cone snail.
Conus striatus, one of the largest, most common species of
piscivorous cone snails, is found from Hawaii to the Red Seaand East Africa. It aggressively stalks its fish prey and can
extend its proboscis at least 6 times the length of its shell.
This allows large specimens of Conus striatus, which can
reach up to 15 cm long, to strike their prey from a considerable
distance. The immediate effect after the prey is struck is a rapid
tetanic paralysis, resulting from a generalized excitotoxic
shock [32]. These venom components acting together are
called ‘‘the lightning strike cabal.’’ Our discovery of con-ikot-
ikot reveals a previously unrecognized mechanistic aspect to
the lightning-strike cabal. Con-ikot-ikot presumably acts on
glutamatergic circuitry in the peripheral nervous system of
fish with the likely targeted circuitry in the vestibular pathway.
Depolarization of neurons by unblocking desensitization
should cause hyperexcitability of the nervous system, leading
to the rapid immobilization of the prey.
Our study of con-ikot-ikot’s action in the mammalian CNS
demonstrates that the toxin produces a large sustained
AMPAR-mediated current in neurons. This finding indicates
that a population of AMPARs on CA1 pyramidal neurons that
might be chronically desensitized becomes activated and
passes current when toxin is present. However, we also show
that the toxin does not activate receptors in the absence of
glutamate, suggesting either that ambient levels of glutamate
are higher than previously estimated [33] or that the toxin has
additional effects, such as interfering with glutamate uptake,
which lead to increased extracellular glutamate. The small
effect of the toxin on AMPAR EPSC decay is consistent with
other work that indicates that desensitization has only a minor
role in determining the EPSC time course at CA1 synapses
[34, 35]. Alternatively, the synapse may not be particularly
accessible to the large peptide toxin. Other studies that used
cyclothiazide to block AMPAR desensitization showed a
prolongation of hippocampal AMPAR-mediated EPSCs [35–
37]. However, this effect could also be attributed to the other
known actions of cyclothiazide, e.g., enhancing and desynch-
ronizing synaptic release [37], increasing AMPAR glutamate
affinity [36, 38], or slowing of deactivation [24].
Con-ikot-ikot also caused a large progressive depression of
AMPA EPSC amplitude. This may be secondary to postsyn-
aptic changes caused by the prolonged DC current. Alterna-
tively, the toxin may cause activation of presynaptic AMPARs
[39], which negatively regulate glutamate release and which
are tonically desensitized by extracellular glutamate levels in
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906the slice. To date, most modulators of AMPARs have been of
limited therapeutic value. Con-ikot-ikot or soluble drugs
modeled on con-ikot-ikot may provide powerful tools to vary
the percentage of chronically desensitized receptors and alter
synaptic transmission.
Experimental Procedures
Biochemistry
200 mg of crude venom isolated from C. striatus was purified by reverse-
phase HPLC via a binary buffer system (buffer A, 0.1% TFA; buffer B,
0.1% TFA, 90% acetonitrile). Gradients were 5%–65% buffer B, 30 min, fol-
lowed by additional separation at 65%–100% buffer B, 10 min. All purifica-
tions were performed with Vydac C18 columns: preparative columns
(22 mm 3 25 cm, 15 mm particle size, 300 A˚ pore size), semipreparative
columns (10 mm 3 25 cm, 5 mm particle size, 300 A˚ pore), or analytical
columns (4.6 mm 3 25 cm, 5 mm particle size, 300 A˚ pore size). Active frac-
tions were further purified by two C18 separations from 23%–45% B90
in 45 min and 25%–40% B90 in 50 min. Purified peptide was sequenced
by the University of Utah Core Facility with Edman N-terminal peptide
sequencing. ESI/MS and MALDI TOF analysis was performed by the Univer-
sity of Utah Mass Spectrometry and Proteomics Core Facility. RNA was iso-
lated from venom ducts by grinding with a mortar and pestle in ice-cold RLT
(RNeasy mini kit QIAGEN). Primers designed to the con-ikot-ikot sequence
were used to perform 50 and 30 RACE to identify the full cDNA sequence.
Recombinant Con-ikot-ikot
cDNA encoding con-ikot-ikot was cloned in-frame with thioredoxin
pET32b+ (Novagen) (pCSW164). E. coli Rosetta-gami B (Novagen) contain-
ing pCSW164 were harvested 4 hr after IPTG induction. Bacteria were lysed
with an Avestin homoginizer in binding buffer (20 mM phosphate, 0.5 M
NaCl, 20 mM imidazole [pH 7.4], and 13 Complete Protease Inhibitors
[Roche]). FPLC purification of the protein fusion was performed with His-
Figure 8. Con-ikot-ikot Blocks Desensitization
of AMPARs
Rapid application of glutamate reveals rapid acti-
vation and subsequent desensitization in the
continued presence of glutamate.
(A) Currents in response to 10 mM glutamate
from outside/out patches pulled from the soma
of mouse hippocampal CA1 neurons. Black
traces expanded from initial region of that shown
in gray.
(A1) Control traces separated by 15 min (no
toxin).
(A2) Current before (left) and 15 min after (right)
incubation with 1 mM con-ikot-ikot.
(B and C) Currents in response to 3 mM glutamate
from outside/out patches pulled from HEK293
cells that expressed vertebrate GluA1 in the
absence of toxin (control) and after incubation
with toxin (B), and in response to repeated long
duration applications of glutamate (C).
trap HP Nickel affinity column (GE healthcare).
Recombinant protein was digested with enteroki-
nase light chain (New England Biolabs: 2 mM
phosphate, 50 mM NaCl, 20 mM imidazole). The
final purification was performed by reverse phase
HPLC. Refolding experiments used a mixture of
oxidized and reduced glutathione (1 mM GSSG,
2 mM GSH, 100 mM Tris, 10 mM EDTA [pH 7.5]).
Protein Electrophoresis
Samples were prepared by adding purified native
protein to RIPA buffer (1% Triton X-100, 0.5%
DOC, 0.1% SDS, 0.15 M NaCl) with 50 mM Tris
(pH 7.5) or 50 mM Tris (pH 7.5) and 1 M NaCl, or
0.01 M Na-acetate (pH 4). Samples were incu-
bated at 37C 1 hr or 4C for pH 4 samples. Equal
volume of sample buffer (6% SDS) with or without DTT (10 mM) were added
to samples and then boiled 10 min before being separated on 15% precast
SDS gel (Biorad). Alternatively, samples were directly added to an equal
volume of SDS buffer with or without DTT.
Reconstitution Studies
Xenopus oocytes were injected with approximately 10 ng cRNA prepared
from p59/2, GluA1(flop); GluA1(flip) plasmid; pRB14, GluA2; pRB312,
GluA3; pK46, GluA4; U08261, GluN1; pNR2A251, GluN2A; pDM1318,
GluA1 flip – LIVBP D60-471. Oocyte electrophysiological recordings were
performed as described previously [40]. Currents recorded in response to
1 mM glutamate. HEK293 cells were transfected with GluA1 (Figure 8) or
GluA1 and stargazin (Figure S3). Glutamate-gated currents were recorded
with rapid piezo-driven exchange of solutions as described previously
(exchange time < 1 ms) [8].
Hippocampal Slices and Recordings
2-week-old Wistar rats were anesthetized with isoflurane and then decapi-
tated in accordance with NIH animal care and use guidelines. Transverse
hippocampal slices (400mm thick) were cut in ice-cold artificial cerebrospinal
fluid (ACSF) containing (mM): 119 NaCl, 2.5 KCl, 2.5 CaCl2, 9 MgSO4,
1 NaH2PO4, 26.2 NaHCO3, 11 glucose equilibrated with 95% O2 and 5%
CO2. Slices were then allowed to recover for at least 1 hr in ACSF at room
temperature (composition as above except for 1.3 mM MgSO4). Whole-cell
patch clamp recordings were made from visually identified CA1 pyramidal
neurons in the presence of 50 mM picrotoxin at room temperature. The
whole-cell solution contained (mM) 115 CsMeSO4, 20 CsCl2, 10 HEPES,
2.5 MgCl2, 4 NaATP, 0.4 NaGTP, 10 NaCreatine, and 0.6 EGTA (pH 7.2).
EPSCs were evoked by electrical stimulation of Schaffer collateral/
commissural axons via a bipolar stimulating electrode placed in stratum
radiatum of CA1 (0.2 Hz stimulation frequency). Cells were voltage-clamped
at 270 mV. Recordings were performed with a Multiclamp 700B patch-
clamp amplifier (Axon Instruments, Foster City, CA); signals were filtered
at 4 kHz, digitized at 10 Hz, and displayed and analyzed online via pClamp
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9079.2 (Axon Instruments). For fast agonist application, out-side-out patches
were pulled from the soma of CA1 pyramidal cells. Currents were elicited
in patches with rapid local perfusion of 10 mM glutamate by means of
a gravity-fed solution system controlled by a solenoid valve. Agonist was
applied typically for 2 s with an estimated exchange time for agonist appli-
cation across the patch of < 10 ms. EPSC decay kinetics were fit with
a double exponential via OriginLab software (Northampton, MA) and are ex-
pressed as a weighted decay time constant. Statistical significance for the
effects of toxin on EPSC decay time constant was tested with a Student’s
t test. NBQX was obtained from Tocris Cookson.
Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.cell.com/current-biology/supplemental/S0960-
9822(09)01118-X.
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